FDA approves Aurobindo’s Cordarone generic

SILVER SPRING, Md. — The Food and Drug Administration has approved Aurobindo’s generic of Cordarone (amiodarone hydrochloride) tablets, the company announced Thursday. The drug is indicated to treat recurrent heart rhythm problems.

 

Aurobindo’s generic will be available in 200-mg dosage strength. The product had U.S. sales of about $24.1 million for the 12 months ending June 2016, according to IMS Health.